SPTX: A Post-IPO Rebound Trade - Borrowed Efficacy, Engineered Safety, and a Tight Float
Seaport Therapeutics (SPTX) is a clinical-stage company focused on neuropsychiatric medicines. The stock trades at a $1.09B market cap with a tight float (~13.8M shares) and meaningful short interest (~3.7M shares as of 10/15/2026). Technicals show bullish momentum while fundamentals reflect typical clinical-stage valuation uncertainty. This trade …